(VIANEWS) - The NASDAQ opens tomorrow, in less than two hours, and today's TherapeuticsMD (NASDAQ: TXMD)'s post-market value is already 4.76% up.
TherapeuticsMD's last close was $2.31, 64.41% below its 52-week high of $6.49.
The last session, NASDAQ ended with TherapeuticsMD (TXMD) dropping 3.75% to $2.31. NASDAQ rose 0.19% to $14,992.97, after two successive sessions in a row of gains, on what was a somewhat bullish trend trading session.
About TherapeuticsMD
TherapeuticsMD, Inc. operates as a pharmaceutical company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY,BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands. The company sells its prescription pharmaceutical products and prenatal vitamin products to wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.
Earnings Per Share
As for profitability, TherapeuticsMD has a trailing twelve months EPS of $4.85.
PE Ratio
TherapeuticsMD has a trailing twelve months price to earnings ratio of 0.48. Meaning, the purchaser of the share is investing $0.48 for every dollar of annual earnings.
Moving Average
TherapeuticsMD's value is below its 50-day moving average of $2.35 and way under its 200-day moving average of $3.41.Yearly Top and Bottom Value
TherapeuticsMD's stock is valued at $2.31 at 17:25 EST, way below its 52-week high of $6.49 and way higher than its 52-week low of $1.95.
More news about TherapeuticsMD (TXMD).